GeoVax Labs, Inc. (GOVX) vs TransCode Therapeutics, Inc. (RNAZ)
A side-by-side comparison of GeoVax Labs, Inc. and TransCode Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GOVX
GeoVax Labs, Inc.
$0.29HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RNAZ
TransCode Therapeutics, Inc.
$1.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Not enough overlapping price history to compare GOVX and RNAZ.
GOVX vs RNAZ: by the numbers
- •GOVX is the larger company ($2M vs $2M market cap).
- •Both run net losses; RNAZ's is the smaller (0.00% vs -862.34% net margin).
Metrics side by side
Valuation
| Metric | GOVX | RNAZ |
|---|---|---|
| P/B ratio | 1.21 | N/A |
Profitability
| Metric | GOVX | RNAZ |
|---|---|---|
| Gross margin | -628.02% | 0.00% |
| Operating margin | -869.34% | 0.00% |
| Net margin | -862.34% | 0.00% |
| ROE | -1160.10% | -30.92% |
| ROIC | -985.20% | -23.73% |
Growth (annualized)
| Metric | GOVX | RNAZ |
|---|---|---|
| Total return CAGR (5Y) | N/A | -93.39% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.